# MVP2 — Final Human + Di Governance Gate & Closure

Timestamp (UTC): 2026-09-15T10:38:19Z
Closure HEAD at start of this gate: `90be591563a7ebcadd5e3e18912fd65aaebe87b9`

This is a governance and evidence-closure activity, not a new implementation phase. No
checkpoint (CP01–CP09) was reopened, no frozen artifact was modified, and no coverage,
threshold, or requirement was strengthened to make this closure look better. This report
formally records the Human + Di final judgment on the completed CP01–CP09 evidence.

---

## A. Executive Decision

> **MVP2 — ACCEPTED WITH EXPLICIT LIMITATIONS — MECHANISM MVP COMPLETE**

MVP2 has successfully demonstrated a real, governed, evidence-backed Agentic QE mechanism
end-to-end on a real System Under Test. The demonstrated end-to-end chain —

**Approved Requirement → Testcase → Test Data → Automation → Real Execution → Evidence → RCA
→ Replanning → Governance**

— was demonstrated for `REQ-ACO-03`. MVP2 has **not** demonstrated broad business-test
coverage or business-level PASS across the Approved SRS. This distinction is preserved
exactly throughout this report.

## B. Scope

MVP2 was intended to demonstrate the *feasibility and operation* of a governed Agentic QE
lifecycle against a real SUT (`https://demowebshop.tricentis.com/`) — not to achieve
comprehensive business-requirement test coverage or a production-grade QE platform. Per
`requirements/MVP2_SRS_v1.0_APPROVED.md` §2.4/§9.1, the approved scope explicitly includes
performance *measurement and validation as a process*, with no numeric SLA approved, and
explicitly defers broad coverage, production security, and CI/CD to later evolution.

## C. Checkpoint Status

| Checkpoint | Final Status | Authoritative Evidence |
|---|---|---|
| CP01 (Discovery/SRS) | Closed | `requirements/MVP2_SRS_v1.0_APPROVED.md` |
| CP02 (Knowledge/RAG) | Closed | `knowledge/`, `docs/CP-MVP2-02-GIT-CHECKPOINT.md` |
| CP03 (Testcase generation) | Closed | `docs/CP-MVP2-03-FINAL-FREEZE-CHECKPOINT.md` |
| CP04 (Test-data generation) | Closed | `docs/CP-MVP2-04-FINAL-IMPLEMENTATION-FREEZE-CHECKPOINT.md` |
| CP05 (Automation generation) | Closed | `docs/CP-MVP2-05-FINAL-IMPLEMENTATION-FREEZE-CHECKPOINT.md` |
| CP06 (Real browser execution) | Closed — GREEN WITH ADVISORIES | `docs/claude-execution-reports/CP-MVP2-06/CP-MVP2-06-GOVERNANCE-CLOSURE-20260914-205228.md` |
| CP07 (RCA/Replanning/Governance) | Closed — GREEN WITH ADVISORIES | `docs/claude-execution-reports/CP-MVP2-07/CP-MVP2-07-EXECUTION-REPORT-20260915-091707.md` |
| CP08 (JMeter performance) | Closed — GREEN WITH ADVISORIES, ZERO ACTIONABLE DEBT | `docs/claude-execution-reports/CP-MVP2-08/CP-MVP2-08-ADVISORY-CLOSURE-RECONCILIATION-20260915-101113.md` |
| CP09 (Unified Final QE Reporting) | Closed | `docs/claude-execution-reports/CP-MVP2-09/CP-MVP2-09-UNIFIED-FINAL-QE-REPORT-20260915-102842.md` |

No checkpoint was reopened by this gate. Re-verified this task via `git diff --stat` against
every specification, freeze checkpoint, and closure/reconciliation report listed above:
**empty — zero drift.**

## D. Evidence Summary

- **10** persisted, `ACCEPTED` testcases (CP03); **25** persisted test-data sets, including
  real, disclosed `REJECTED` (2) and `POSSIBLE_DUPLICATE` (6) records (CP04).
- **13** persisted automation artifacts on disk (3 git-committed multi-locator variants; 10
  additional real, on-disk-only standard artifacts per the CR-001-era persistence decision) —
  **4 `ACCEPTED`, 9 `UNSUPPORTED_NEEDS_CLARIFICATION`** (CP05).
- **35** real, business-testcase-linked execution records (fixture noise deterministically
  excluded): **31 `NOT_EXECUTED`, 1 `PASS`, 3 `FAIL`** — every `NOT_EXECUTED` traced to the
  identical, disclosed cause (governance-blocked automation, never silently executed) (CP06).
- **4** real RCA records, **4** replanning decisions, **4** governance decisions, all
  `HIGH` confidence, prohibited-change guard passed on every real check, CR-002 status
  `OPEN_NOT_AUTHORIZED` on every one (CP07).
- **2** real, independently-verified JMeter executions (WSL/Linux-native and Windows-native),
  each 30/30 samples, 0 errors, capability `PASS`, numeric SLA `INCONCLUSIVE` (CP08).
- One authoritative Unified Final QE Report cross-checking every one of the above figures
  against a live `reporting.gather.gather_all()` run (CP09), re-verified identical again by
  this gate (sec. L below).

## E. End-to-End Demonstration — REQ-ACO-03

The one requirement in this MVP2 corpus with a fully populated, real, evidenced chain:

```
REQ-ACO-03 (Approved SRS, APPROVED -- BASELINED v1.0)
  -> TC-REQ-ACO-03-01 (persisted testcase, ACCEPTED, CP03)
  -> TD-TC-REQ-ACO-03-01-01 / -02 (persisted test data, ACCEPTED, CP04)
  -> ML-PW-TC-REQ-ACO-03-01-01(-D01/-D02) (persisted automation, ACCEPTED, CP05 --
     the original single-candidate PW-TC-REQ-ACO-03-01-01 was itself
     UNSUPPORTED_NEEDS_CLARIFICATION; ACCEPTED status was reached only via the
     separate, additive multi-locator/CR-002-investigation package)
  -> REALISM-SLICE-EXEC-D01 / -D02, MULTI-LOCATOR-VERTICAL-SLICE-EXEC-02
     (real Chromium execution against the real SUT, CP06)
  -> real, persisted step/assertion/evidence-reference data (runs/, local-disk, CP06)
  -> RCA-REALISM-SLICE-EXEC-D01 (persisted, HIGH confidence, ENVIRONMENT_ISSUE/TIMEOUT,
     testcase-content-limitation root cause, CP07)
  -> REPLAN-RCA-REALISM-SLICE-EXEC-D01 (HUMAN_REVIEW_REQUIRED, CP07)
  -> GOV-REALISM-SLICE-EXEC-D01 (ACTION_DEFERRED_TO_HUMAN, prohibited-change guard passed,
     CR-002 status OPEN_NOT_AUTHORIZED, CP07)
```

The real execution result was a genuine **FAIL**. It is not, and has never been, rewritten as
PASS. The failure was root-caused by the established testcase-content limitation (every real
testcase shares a generic, minimal step structure lacking a precondition-establishing
business step before the fields its own real, evidenced locators target) — this is evidence
that the governance mechanism functions correctly (a real failure, honestly classified,
correctly deferred to Human + Di rather than silently resolved), not evidence to be hidden.

## F. Coverage Reality

| Dimension | Count | Percentage of 35 Approved Requirements |
|---|---|---|
| Approved SRS requirements | 35 | 100% |
| Requirements with a generated testcase | 4 (`REQ-ACO-03`, `REQ-CART-03`, `REQ-PAY-01`, `REQ-REG-01`) | 11.4% |
| Requirements with automation that reached real browser execution | 1 (`REQ-ACO-03`) | 2.9% |
| Requirements with a verified, business-level PASS execution | **0** | **0%** |

This is recorded as a limitation of the current MVP capability, not disguised as broad
coverage. `UNSUPPORTED_NEEDS_CLARIFICATION`, `NOT_EXECUTED`, `BLOCKED`, and `FAIL` are never
reinterpreted as `PASS` anywhere in this MVP2 corpus or in this closure.

## G. Performance

Per CP08's reconciled evidence (`docs/claude-execution-reports/CP-MVP2-08/CP-MVP2-08-ADVISORY-CLOSURE-RECONCILIATION-20260915-101113.md`):

### Capability demonstration
**PASS** — both real, independently-verified JMeter executions (WSL/Linux-native and
Windows-native) completed 30/30 real samples with 0 errors against the real SUT.

### Numeric performance SLA
**INCONCLUSIVE** — the Approved SRS contains no approved numeric performance threshold
(§9.2). No threshold was invented or retroactively established. The missing threshold is a
**Human/Project decision**, not an MVP2 implementation defect.

## H. Governance

- **Evidence hierarchy** preserved end-to-end: Approved baseline → direct system evidence →
  current testing artifact → historical evidence → agent inference, with current, direct
  evidence never overridden by historical or inferred information (CP07's own RCA discipline,
  reused unchanged by CP09).
- **Frozen specifications**: every CP01–09 specification and freeze checkpoint, the Approved
  SRS, and every CP06/07/08/09 closure/reconciliation report remain byte-for-byte unchanged
  since their own freeze — re-verified this task (sec. L).
- **Human approval boundary**: every real point in this corpus requiring a change beyond a
  checkpoint's own frozen authority (richer testcase authorship, CR-002, numeric NFR
  thresholds) was deferred to Human + Di via a real, persisted governance record — never
  self-authorized.
- **Prohibited-change protection**: a real, SHA-256 content-hash guard over the curated
  frozen-artifact set, checked on every real CP07 governance run — passed on all 4.
- **RCA/replanning**: reuses the frozen CP06 failure taxonomy verbatim; no artificial
  `REPLAN_ALLOWED` was ever manufactured; the real, evidence-justified outcomes were 3×
  `HUMAN_REVIEW_REQUIRED` and 1× `REPLAN_NOT_ALLOWED`.

## I. Limitations

Carried forward, verified against the authoritative evidence, not converted into new
implementation tasks:

1. Testcase-content limitation (generic, minimal step structure; no precondition-establishing
   business step).
2. Limited generated-testcase coverage — 4/35 Approved SRS requirements.
3. Limited real-execution coverage — 1/35 requirements ever reached the real browser.
4. Zero verified business-level PASS across the Approved SRS.
5. `DATA-OQ-01` — shared-instance data-reset/isolation policy unresolved at the SRS level.
6. `AUTOMATION_ID_COLLISION_ADVISORY` — frozen `automation/generate.py` naming does not
   incorporate `test_data_set_id`.
7. No reusable authenticated-session fixture exists.
8. `ACTION_TYPE_EVIDENCE_ADVISORY` (inherited from CP05).
9. Numeric performance threshold — a standing Human/Project decision (SRS §9.2).
10. Bounded, single-category, GET-only CP08 performance scenario (deliberate, shared-instance-
    safe design).
11. Shared, third-party SUT reproducibility — no SLA, no exclusive ownership; a real,
    directly-observed transient failure was disclosed and did not change either persisted
    CP08 evidence run.
12. External, unvendored JMeter/JRE dependency (same stance as this project's existing,
    unvendored Playwright browser dependency).
13. Windows-first portability limitation — this project's primary execution environment is a
    Windows Python venv reached via WSL interop; `persistence.envelope.load_latest`'s
    cross-platform path handling remains a disclosed, deliberately parked advisory.
14. CR-002 (runtime locator fallback/self-healing) not authorized (sec. K).

None of the above is converted into a new implementation task by this closure.

## J. Open Human/Project Decisions

- **Numeric NFR performance thresholds** (response time, throughput, error rate, baseline
  load, concurrency, availability) — Approved SRS §9.2. This remains genuinely open; MVP2
  closure does not resolve it and does not need to.
- **Whether to authorize** a future, separately-governed task to author richer testcase
  content and/or CR-002 — the two items CP07's own real `HUMAN_REVIEW_REQUIRED` replanning
  decisions identified as the only paths toward a verified business-level PASS.
- The 13 Approved SRS §13 open/parked items (already pre-ruled non-blocking to the v1.0
  baseline by the Human Owner).
- Disposition of the untracked `requirements/Post MVP Enhancments.md` human note and the
  untracked `automation/generated/PW-*` / `runs/` / `reports/execution_summaries/BATCH2-TEST*`
  artifacts (carried forward unchanged from CP06 closure onward).

## K. CR-002

**OPEN — NOT AUTHORIZED.**

Runtime locator fallback/self-healing was deliberately not introduced anywhere in MVP2
because it required formal authorization that was never granted. It is not implemented, and
is not represented as implemented, anywhere in this repository or in this closure
(`docs/CP-MVP2-CR-002-RUNTIME-LOCATOR-FALLBACK-PROPOSAL.md`, status re-verified this task:
`PROPOSED — NOT IMPLEMENTED. NOT AUTHORIZED.`).

## L. Post-MVP Boundary

Explicitly parked, outside MVP2 completion, not implemented by this or any prior task:

richer testcase authorship; stronger testcase-quality validation; multiple evidence-backed
locators as a general capability; runtime locator fallback/self-healing (CR-002); improved
executable Playwright artifacts; reusable Playwright components; richer human-consumable
Excel artifacts; broader execution coverage; stronger artifact lifecycle enhancements
(e.g. resolving the automation-ID collision at its frozen source); advanced performance
engineering; security/penetration testing; Linux/macOS portability; CI/CD integration;
distributed browser execution.

This section defines a boundary; it creates no new task.

## Final Evidence Integrity Audit (read-only; performed this task)

1. Current Git HEAD: `90be591563a7ebcadd5e3e18912fd65aaebe87b9`.
2. `origin/main`: `90be591563a7ebcadd5e3e18912fd65aaebe87b9` — identical (`git fetch` + `git rev-parse` both re-run this task).
3. CP01–CP09 closure reports: all present, all inspected, none altered.
4. Approved SRS: `requirements/MVP2_SRS_v1.0_APPROVED.md` — unchanged.
5. Frozen checkpoint specifications: CP01–CP09, all unchanged (`git diff --stat` empty).
6. CP06/07/08 governance-closure/reconciliation artifacts: unchanged.
7. CP09 Unified Final QE Report: unchanged.
8. Representative real execution evidence (`REALISM-SLICE-EXEC-D01`, `BATCH2-MECHANISM-CHECK-01`, and the full 35-record real corpus): re-read via `reporting.gather.gather_real_execution_results()` this task; unchanged.
9. CP07 RCA evidence: re-read via `reporting.gather.gather_rca()` this task; 4/4 records, all HIGH confidence, all CR-002 `OPEN_NOT_AUTHORIZED`; unchanged.
10. CP08 real JMeter evidence: re-read via `reporting.gather.gather_performance()` this task; both runs 30/30 samples, 0 errors, `PASS`/`INCONCLUSIVE`; unchanged.
11. No frozen-artifact drift: confirmed (see sec. C).
12. No fabricated execution evidence: every number in this report traces to a real, persisted artifact or a real, re-run `reporting.gather.gather_all()` call; none was invented or estimated.

## Final Regression

Existing full regression suite re-run this task (no implementation change made):
**360 passed, 1 skipped** (`.venv/Scripts/python.exe -m pytest tests/ -q`) — the one honest
skip (CP08's live-execution test, requiring `JMETER_EXECUTABLE`/`JAVA_HOME` not configured in
this default environment) is unchanged and not hidden.

## M. Final Conclusion

> MVP2 is accepted as a completed Mechanism MVP. The implementation demonstrates the governed
> Agentic QE lifecycle end-to-end on a real SUT, while broad requirement coverage and
> business-level PASS validation remain outside the demonstrated MVP capability and are
> explicitly carried forward for future evolution.

---

# Final Status

# MVP2 — ACCEPTED WITH EXPLICIT LIMITATIONS

# MECHANISM MVP COMPLETE

This is explicitly **not**: Production Ready; Full Application Coverage; Fully Autonomous QE;
100% Requirement Execution; Business PASS; or Production-grade self-healing.
